The Cardiovascular And Soft Tissue Repair Patch Market Size is valued at 4063.50 Mn in 2023 and it is predicted to reach 8139.69 Mn by the year 2031 at an 9.25% CAGR during the forecast period for 2024-2031.
Key Industry Insights & Findings from the Report:
- Increasing occurence of cardiovascular diseases is driving the cardiovascular and soft tissue repair patch market.
- Increasing awareness about soft tissue injuries and educational initiatives are key drivers for market growth.
- North America dominated the market and accounted for a global revenue share in 2023.
- The key challenge for the cardiovascular and soft tissue repair patch market is the high cost of surgical procedures.
Cardiovascular and soft tissue repair patches are used to repair tissue procedures such as vascular repair, soft tissues, and restoration. The growing prevalence of heart defects such as ventricular septal and atrial septal defects in medical events and sports wounds are the major factor propelling the demand for cardiovascular and soft tissue repair patches market. The rising prevalence of hernias such as inguinal hernia, congenital diaphragmatic hernias, and others are anticipated to propel the adoption of these patches globally. Restoration of inguinal hernias is one of the most generally performed general surgeries.
According to The National Digestive Diseases Information Clearinghouse (NDDIC), more than one million hernia repairs are performed in the U.S. each year. Among the total hernia procedure, about 800,000 for restoration inguinal hernias, and the remaining are for other kinds of hernias. The preference for minimally invasive surgeries and an increase in the prevalence of acquired cardiovascular & soft tissue abnormalities are expected to fuel the growth of the cardiovascular & soft tissue repair patch market globally. Moreover, growing strategic mergers and acquisitions among the key players operating in the market, growing health care expenditure is likely to supplement the global market.
Competitive Landscape
Some of The Key Players in The Cardiovascular And Soft Tissue Repair Patch Market:
- Edwards Lifesciences Corporation
- Gore & Associates, Inc.
- BD (Becton Dickinson)
- CryoLife, Inc.
- Baxter International, Inc.
- Johnson & Johnson (Medical Devices Business Services, Inc.)
- Aesculap, Inc. (a B. Braun company)
- Nurami Medical Nanofiber Technology
- Medtronic
- FOC Medical S.A.
- Admedus
- Bone Bank Allografts
- Braile Biomédica
- Glycar SA Pty Ltd.
- LeMaitre Vascular, Inc.
- Medprin Regenerative Medical Technologies Co., Ltd.
- CorMatrix, Inc.
- Terumo Corporation
- Lamed GmbH
- South America Implants S.A.
- Other Prominent Players
Market Segmentation
The Cardiovascular & Soft Tissue Repair Patch Market is a segment based on product type, application, end-user, and geography. In terms of product type, the global market is segregated into synthetic patch and biologic patch. The biologics segment is estimated to register a high share in the global cardiovascular & soft tissue repair patch market in 2024. The biologics patch segment is further segmented into the xenogeneic patch and allogeneic patch. The biologic patch is used in soft tissue repair, and speedy progress in tissue engineering and biomaterial are some of the key factors that are predictable to boost the cardiovascular & soft tissue repair patch market over the estimated timeframe. Additionally, the companies in the cardiovascular & soft tissue repair patch market are investing more in research and development activities to develop technologically advanced products such as biologic patches is expected to boost the growth of the market significantly.
Based on the application, the market is segmented into soft tissue repair and cardiovascular repair. The soft tissue repair segment is further segmented as abdominal wall reconstruction, hernia repair, thoracic wall reconstruction, dural reconstruction, and others. The cardiovascular repair segment is further segmented into vascular reconstruction and cardiac reconstruction. The soft tissue repair segment is estimated to account for the largest share in 2024 in the global market. The growing surgical procedures such as hernia repair, dural reconstruction, abdominal wall reconstruction, etc. are propelling the growth of the segment in the global market. Based on end-user, the global soft tissue repair and cardiovascular repair market is segmented into hospitals, ambulatory surgical centers, and specialty clinics.
Based on geography, the Global Cardiovascular & Soft Tissue Repair Patch Market has been segmented into North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. In terms of revenue, North America is estimated to account for the largest share in the global market in 2024. The high prevalence of cardiac diseases and a large number of surgeries carried out in the U.S. are expected to boost the growth of the market significantly in the region. Moreover, the growing consumption of junk food and adopting a sedentary lifestyle are propelling cardiovascular diseases in the region. Moreover, the presence of a well-established healthcare system and high adoption of minimally invasive surgeries are expected to propel the demand for the cardiovascular & soft tissue repair patch market in North America.
Recent Developments:
- In April 2023, Aziyo Biologics, Inc. established a distribution deal with LeMaitre Vascular, Inc., a company that offers vascular devices, implants, and services. Aziyo Biologics specializes in the development and marketing of biologic products that improve the compatibility between medical equipment and the patients who need them. Under the terms of the deal, Aziyo has given LeMaitre exclusive distribution rights for its cardiovascular products in the United States.
The Cardiovascular And Soft Tissue Repair Patch Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 4063.50 Mn |
|
Revenue Forecast In 2031 |
USD 8139.69 Mn |
|
Growth Rate CAGR |
CAGR of 9.25% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million, Volume (Unit), and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product Type, By Application, By End-Users |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Edwards Lifesciences Corporation, BD (Becton Dickinson), W. L. Gore & Associates, Inc., CryoLife, Inc., Baxter International, Inc., Aesculap, Inc. (a B. Braun company), Johnson & Johnson (Medical Devices Business Services, Inc.), Nurami Medical Nanofiber Technology, LeMaitre Vascular, Medtronic, FOC Medical S.A., Admedus, Bone Bank Allografts, Braile Biomédica, Glycar SA Pty Ltd., Inc., CorMatrix, Inc., Medprin Regenerative Medical Technologies Co., Ltd., Terumo Corporation, South America Implants S.A., and Lamed GmbH among others |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
